C₂N Diagnostics, LLC (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.c2n.com&esheet=53905942&newsitemid=20240306427979&lan=en-US&anchor=C%26%238322%3BN+Diagnostics%2C+LLC&index=1&md5=4811335dc8de18b0a6404d5218faa687), a leader in advanced brain health diagnostics, and Eisai Inc., a “human health care company,” have announced Eisai has made an investment of up to 15 million USD in C₂N.
C₂N executives say the investment reflects the two companies’ shared desire…